Clinical trial
Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of…
NCT00254774 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00254774 |
|---|---|
| Title | Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling |
| Official title | Pilot Study of the Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling: an Open Trial |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | quetiapine fumarate or valproate |
| Enrollment | 44 |
| Start date | Jan 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | Nov 17, 2005 |
| Last update posted | Dec 18, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: